Volume 10 Issue 5
Sep.  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(5): 513-520
Branch of Organ Transplantation of Chinese Medical Association. Technical operation specification for tissue matching and immune monitoring techniques in renal transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 513-520. doi: 10.3969/j.issn.1674-7445.2019.05.009
Citation: Branch of Organ Transplantation of Chinese Medical Association. Technical operation specification for tissue matching and immune monitoring techniques in renal transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 513-520. doi: 10.3969/j.issn.1674-7445.2019.05.009
shu

Technical operation specification for tissue matching and immune monitoring techniques in renal transplantation (2019 edition)

doi: 10.3969/j.issn.1674-7445.2019.05.009
  • Received Date: 2019-06-16
    Available Online: 2021-01-19
  • Publish Date: 2019-09-15
    Abstract
    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    APANIUS V, PENN D, SLEV PR, et al. The nature of selection on the major histocompatibility complex[J]. Crit Rev Immunol, 2017, 37(2/3/4/5/6):75-120. DOI: 10.1615/CritRevImmunol.v37.i2-6.10.
    [2]
    SINGH SP, MISHRA BN. Major histocompatibility complex linked databases and prediction tools for designing vaccines[J]. Hum Immunol, 2016, 77(3):295-306. DOI: 10.1016/j.humimm.2015.11.012.
    [3]
    SOUTH AM, GRIMM PC. Transplant immuno-diagnostics: crossmatch and antigen detection[J]. Pediatr Nephrol, 2016, 31(6):897-905. DOI: 10.1007/s00467-015-3145-z.
    [4]
    KRANSDORF EP, PANDO MJ, GRAGERT L, et al. HLA population genetics in solid organ transplantation[J]. Transplantation, 2017, 101(9):1971-1976. DOI: 10.1097/TP.0000000000001830.
    [5]
    龚非力.医学免疫学[M].北京:科学出版社, 2013.
    [6]
    窦肇华, 张远强, 郭顺根, 等.免疫细胞学与疾病[M].北京:中国医药科技出版社, 2004.
    [7]
    赵卫东, 周茂华.实用流式细胞分析技术[M].广州:广东科技出版社, 2000.
    [8]
    王建中.临床流式细胞分析[M].上海:上海科学技术出版社, 2005.
    [9]
    SHAHEEN FA. Organ transplantation in Saudi Arabia[J]. Transplantation, 2016, 100(7):1387-1389. DOI: 10.1097/TP.0000000000001295.
    [10]
    ALEXANDER SI, CLAYTON PA, CHADBAN SJ. Organ transplantation in Australia[J]. Transplantation, 2017, 101(5):891-892. DOI: 10.1097/TP.0000000000001621.
    [11]
    PASCUAL J, ZUCKERMANN A, DJAMALI A, et al. Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation--a review[J]. Transplant Rev (Orlando), 2016, 30(2):85-91. DOI: 10.1016/j.trre.2015.12.002.
    [12]
    IDICA A, EVERLY MJ. Donor-specific HLA antibodies: a review of data published in 2016[J]. Clin Transpl, 2016, 32:13-22.
    [13]
    WEBER LT. Preexisting anti-HLA donor-specific antibodies in pediatric renal transplant recipients - a new challenge? [J]. Pediatr Transplant, 2017, 21(8). DOI: 10.1111/petr.13085.
    [14]
    KARADENIZ ST, AKGUL SU, OGRET Y, et al. Corrected panel-reactive antibody positivity rates for hypersensitized patients in Turkish population with calculated panel-reactive antibody software[J]. Transplant Proc, 2017, 49(3):445-447. DOI: 10.1016/j.transproceed.2017.01.032.
    [15]
    LEE N, PARK HS, IN JW, et al. Association of HLA types with non-specific binding of negative control beads in luminex panel reactive antibody (PRA) screening assay[J]. Clin Lab, 2017, 63(1):169-174. DOI: 10.7754/Clin.Lab.2016.160713.
    [16]
    HUBER L, LACHMANN N, NIEMANN M, et al. Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients[J]. Transpl Int, 2015, 28(6):710-719. DOI: 10.1111/tri.12533.
    [17]
    刘艳荣.实用流式细胞术[M].北京:北京大学医学出版社, 2010.
    [18]
    吴丽娟.临床流式细胞学检验技术[M].北京:人民军医出版社, 2010.
    [19]
    KLAVER Y, KUNERT A, SLEIJFER S, et al. Adoptive T-cell therapy: a need for standard immune monitoring[J]. Immunotherapy, 2015, 7(5):513-533. DOI: 10.2217/imt.15.23.
    [20]
    SOLÉ C, LARREA E, DI PINTO G, et al. MiRNAs in B-cell lymphoma: molecular mechanisms and biomarker potential[J]. Cancer Lett, 2017, 405:79-89. DOI: 10.1016/j.canlet.2017.07.020.
    [21]
    VOSS M, BRYCESON YT. Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans[J]. Clin Immunol, 2017, 177:29-42. DOI: 10.1016/j.clim.2015.11.004.
    [22]
    SAFA K, CHANDRAN S, WOJCIECHOWSKI D. Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects[J]. Drugs, 2015, 75(16):1843-1852. DOI: 10.1007/s40265-015-0487-6.
    [23]
    VAN DOESUM WB, ABDULAHAD WH, VAN DIJK MC, et al. Characterization of urinary CD4+ and CD8+ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection[J]. Transpl Infect Dis, 2014, 16(5):733-743. DOI: 10.1111/tid.12273.
    [24]
    SCHACHTNER T, STEIN M, REINKE P. Sepsis after renal transplantation: clinical, immunological, and microbiological risk factors[J]. Transpl Infect Dis, 2017, 19(3). DOI: 10.1111/tid.12695.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (449) PDF downloads(143) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return